Pulmonary hypertension in chronic lung disease and hypoxia
Open accessThe DOI matches its Crossref record; 94 of the 94 references it cites were found in a registry or an index.
Abstract
Pulmonary hypertension (PH) frequently complicates the course of patients with various forms of chronic lung disease (CLD). CLD-associated PH (CLD-PH) is invariably associated with reduced functional ability, impaired quality of life, greater oxygen requirements and an increased risk of mortality. The aetiology of CLD-PH is complex and multifactorial, with differences in the pathogenic sequelae between the diverse forms of CLD. Haemodynamic evaluation of PH severity should be contextualised within the extent of the underlying lung disease, which is best gauged through a combination of physiological and imaging assessment. Who, when, if and how to screen for PH will be addressed in this article, as will the current state of knowledge with regard to the role of treatment with pulmonary vasoactive agents. Although such therapy cannot be endorsed given the current state of findings, future studies in this area are strongly encouraged.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The OPTN/UNOS registry data demonstrate that Group 3 pulmonary hypertension is common in patients with advanced CF, ILD, and COPD and is associated with increased oxygen requirements and increased mortality.(294–299)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [294]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
Lettieri, C. J., Nathan, S. D., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Chest · doi:10.1378/chest.129.3.746 · Cited by 879
Self-citationSildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial
Ghofrani, H. A., Wiedemann, R., Rose, F., Schermuly, R. T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W., & Grimminger, F. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11024-5 · Cited by 769
Self-citationSevere Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease
Chaouat, A., Bugnet, A.-S., Kadaoui, N., Schott, R., Enache, I., Ducoloné, A., Ehrhart, M., Kessler, R., & Weitzenblum, E. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200401-006oc · Cited by 714
Pulmonary Hypertension in Chronic Lung Diseases
Seeger, W., Adir, Y., Barberà, J. A., Champion, H., Coghlan, J. G., Cottin, V., De Marco, T., Galiè, N., Ghio, S., Gibbs, S., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.10.036 · Cited by 673
Self-citationA Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002110 · Cited by 634
Consensus Statement on Chronic and Subacute High Altitude Diseases
León-Velarde, F., Maggiorini, M., Reeves, J. T., Aldashev, A., Asmus, I., Bernardi, L., Ge, R.-L., Hackett, P., Kobayashi, T., Moore, L. G., et al. (2005) · High Altitude Medicine & Biology · doi:10.1089/ham.2005.6.147 · Cited by 630
Treatment of Idiopathic Pulmonary Fibrosis With Ambrisentan: A Parallel, Randomized Trial
Raghu, G., Behr, J., Brown, K. K., Egan, J. J., Kawut, S. M., Flaherty, K. R., Martinez, F. J., Nathan, S. D., Wells, A. U., Collard, H. R., et al. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-9-201305070-00003 · Cited by 553
Self-citationKESSLER, R., FALLER, M., FOURGAUT, G., MENNECIER, B., & WEITZENBLUM, E. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.159.1.9803117 · Cited by 549
Obesity-Associated hypoventilation in hospitalized patients: prevalence, effects, and outcome
Nowbar, S., Burkart, K. M., Gonzales, R., Fedorowicz, A., Gozansky, W. S., Gaudio, J. C., Taylor, M. R. G., & Zwillich, C. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.08.022 · Cited by 512
Clinical features of paediatric pulmonary hypertension: a registry study
Berger, R. M., Beghetti, M., Humpl, T., Raskob, G. E., Ivy, D. D., Jing, Z.-C., Bonnet, D., Schulze-Neick, I., & Barst, R. J. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61621-8 · Cited by 508
Cited by
Items 601–700 of 834
Heart Failure and Pulmonary Hypertension
Naderi, N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-80915-3.00021-1
General principles of ILD diagnosis and management
Wickremasinghe, M. I. Y., Hewitt, R. J., & Wells, A. U. (2017) · CRC Press eBooks · doi:10.1201/9781003451259-6
Weatherald, J. C., Mai, V., & Provencher, S. (2020) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2020.1725791
Self-citationMalaspinas, I. (2019) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:123504
Idiopathic Pulmonary Fibrosis-Treatment and Management
Collins, B. F., & Raghu, G. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11455-2
Pulmonale Hypertonie: Update 2019
Rosenkranz, S. (2019) · Der Klinikarzt · doi:10.1055/a-1014-6954
Current Clinical Management and Basic Research in Pediatric Pulmonary Hypertension
Nagai, A. (2019) · Japanese Society of Pediatric Cardiology and Cardiac Surgery · doi:10.9794/jspccs.35.136
The evolution of the European Respiratory Journal : ready for the new decade!
Chalmers, J. D., Reeves, E. L., Bullen, N. J., & Kolb, M. R. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.02503-2019
Gonda, I. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202002-087le
ЛЕГОЧНАЯ ГИПЕРТЕНЗИЯ: ОТ ABEL AYERZA ДО НАШИХ ДНЕЙ (ОБЗОР ЛИТЕРАТУРЫ)
Поляков, К. В. (2019) · Университетская клиника · doi:10.26435/uc.v0i1(30).298
Group 3 PH: Clinical Features and Treatment
Aryal, S., Ahmad, K., & Nathan, S. D. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11655-1
Self-citationFabiana, V., Partiningrum, D. L., Budiono, B. P., & Kholis, F. N. (2020) · Jurnal Kedokteran Diponegoro (Diponegoro Medical Journal) · doi:10.14710/dmj.v9i3.27498
A Comprehensive Guide to Lung Transplantation for the Recipient With Pulmonary Fibrosis
Kolaitis, N. A., & Shah, R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00080-9
Sakamaki, F., & Asano, K. (2021) · Circulation Journal · doi:10.1253/circj.cj-21-0030
Pulmonary hypertension: clinical phenotypes and non-invasive risk stratification
Lewis, R. A. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Identifying New Targets for Treatment of Pulmonary Hypertension
Trammell, A. W., & Hart, C. M. (2021) · CHEST Journal · doi:10.1016/j.chest.2020.10.065
Church, C., Gin‐Sing, W., Grady, D., Johnson, M., Kiely, D. G., Lordan, J. L., Turner, N., Wort, S. J., & Condliffe, R. A. (2021) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2021.1931129
Piccari, L., Bernardo, R. J., Rodriguez, D. A., Vitulo, P., Wort, S. J., & Sahay, S. (2021) · Pulmonary Circulation · doi:10.1177/20458940211018074
Pulmonary Arterial Hypertension in a Patient with Connective Tissue Disease and ALCAPA Syndrome
Wong, W., Ho, W., Chu, J., & Luo, S. (2021) · Respiratory Case Reports · doi:10.5505/respircase.2021.45722
Pulmonale Hypertonie und Rechtsherzinsuffizienz
Rosenkranz, S. (2021) · Aktuelle Kardiologie · doi:10.1055/a-1511-2519
Bryant, A. J., & Pérez, V. D. J. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217882
Pulmonary Hypertension - A Distinct Perspective
Sahu, A. K., & Kumar, S. (2021) · Journal of Evidence Based Medicine and Healthcare · doi:10.18410/jebmh/2021/438
Shudueva, A. R., Mizernitsky, Y. L., Groznova, O. S., & Agapitov, L. I. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-17-300-309
Pulmonale Hypertonie: Differenzialdiagnostik und therapeutische Konsequenzen
Rosenkranz, S. (2021) · Kardiologie up2date · doi:10.1055/a-1165-7581
(2021) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-20.4.i
Transpulmonary gradient as a predictor for outcomes after lung transplantation
Chan, E. G., Madde, A., Furukawa, M., Coster, J. N., Ryan, J. P., Luketich, J. D., & Sánchez, P. G. (2022) · Shanghai Chest · doi:10.21037/shc-21-22
Olschewski, H. (2022) · Springer eBooks · doi:10.1007/978-3-662-63651-0_30
Self-citationMarín-Oto, M. (. (2021) · Depósito Académico Digital Universidad de Navarra (University of Navarra) · doi:10.15581/10171/63285
Faculty Opinions recommendation of An overview of the 6th World Symposium on Pulmonary Hypertension.
Pérez, V. D. J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735150591.793561112
Weatherald, J. C., Mehta, S., & Hirsch, A. M. (2021) · Canadian Journal of Respiratory Critical Care and Sleep Medicine · doi:10.1080/24745332.2021.1888040
Pérez, V. D. J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734628296.793561120
Palazzini, M., Galiè, N., & Manes, A. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780198849346.003.0063
Erratum: Aktuelle Definition und Diagnostik der pulmonalen Hypertonie
Lange, T. J., Borst, M. M., Ewert, R., Halank, M., Klose, H. F. E., Leuchte, H. H., Meyer, F. J., Seyfarth, H.-J., Skowasch, D., Wilkens, H., et al. (2020) · Pneumologie · doi:10.1055/a-1221-5775
Bull, T. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.734628296.793568450
General Principles of ILD: Diagnosis and Management
Lee, J. S., & Wells, A. U. (2021) · Elsevier eBooks · doi:10.1016/b978-0-08-102723-3.00164-5
Plaučių arterijos hipertenzijos diagnostikos ir gydymo šiandienos iššūkiai
Hoppenot, D. (2022) · Pulmonology and allergology · doi:10.37499/pia.962
Cardiovascular changes in chronic bronchopulmonary diseases in children
Sciuca, S., Cepraga, V., Balanetchi, L., Rotaru-Cojocari, D., Selevestru, R., & Ina, P. (2022) · Bulletin of the Academy of Sciences of Moldova Medical Sciences · doi:10.52692/1857-0011.2022.1-72.27
Mon sommeil, mon coeur, mes vaisseaux
Lahmar, Z. M., Lamia, B., Planquette, B., & Jutant, E. (2022) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(22)00040-4
Diagnostic and Therapeutic Challenges for Patients with Pulmonary Hypertension due to Lung Diseases
Ribeiro, D. S., Godinas, L., & Delcroix, M. (2022) · Barcelona Respiratory Network · doi:10.23866/brnrev:2022-m0069
van Dijk, M. (2022) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.233391908
Karyana, L. (2022) · Science Insights · doi:10.15354/si.22.re078
Exercise for Systemic and Pulmonary Arterial Hypertension: Killing Two Birds with One Stone
Vriz, O. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-07958-0_13
Mlakar, P., Lestan, D., & Salobir, B. (2022) · Slovenian Medical Journal · doi:10.6016/zdravvestn.3330
Pulmonary hypertension and cardiac involvement in sarcoidosis
Mathijssen, H. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1567
Zhang, R., Wu, Y. T., Wang, L., Gong, S., Jiang, R., Jiang, Q., Wu, B., Chen, X., Wu, C., Yu, Y., et al. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000004293
Sarcoidosis-associated pulmonary hypertension
Kašiković-Lečić, S., Obradović, D., Sazdanić-Velikić, D., Popović, M., Javorac, J., & Živanović, D. (2022) · Sestrinska rec · doi:10.5937/sestrec2285026k
Interstitial lung diseases and secondary pulmonary hypertension
Belić, S., Marić, N., Đurđević, N., Golubovic, A., Milivojević, I., Geratović, M., Nikolić, N., Čokrlić, I., & Stjepanović, M. (2023) · Srpski medicinski casopis Lekarske komore · doi:10.5937/smclk4-41136
Abubakar, M., Hartopo, A. B., Trisnawati, I., Budiono, E., Anggrahini, D. W., & Dinarti, L. K. (2023) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005502202307
Feng, Y., Zhao, Q., Zhang, X., Wang, X., & Han, W. (2023) · Research Square · doi:10.21203/rs.3.rs-3090030/v1
Rosenkranz, S. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62939-0_30-1
Highlights del 56° Congreso SEPAR
Sánchez-Salcedo, P., Llanos-González, A. B., Arenas, S. D., Collado, N. C., García, A. R., Sánchez‐Zaballos, M., & Alonso, T. (2023) · Open Respiratory Archives · doi:10.1016/j.opresp.2023.100265
Pediatric Pulmonary Hypertension
Haarman, M. G., & Berger, R. M. F. (2023) · Springer eBooks · doi:10.1007/978-3-030-42937-9_92-2
Yağmur, B., Kayıkçıoğlu, M., Şimşek, E., Nalbantgil, S., & Kültürsay, H. (2023) · Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · doi:10.5543/tkda.2023.65724
What changed after the 2022 guidelines for pulmonary hypertension?
Guarino, D., Ballerini, A., & Manes, A. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.10.029
Pulmonale Hypertonie – Die neue ESC-Leitlinie
Held, M., & Wilkens, H. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1966-9703
Daher, A., & Klose, H. F. E. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-2012-0856
Rosenkranz, S., Frantz, S., Dumitrescu, D., Eichstaedt, C. A., Ghofrani, H. A., Opitz, C. F., Wilkens, H., & Hoeper, M. M. (2023) · Die Kardiologie · doi:10.1007/s12181-023-00652-x
应, 瑞. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122777
Rosenkranz, S. (2023) · Springer Reference Medizin · doi:10.1007/978-3-662-62932-1_30
Bai, J.-W., Mao, B., Gao, Y., Wang, L., Cao, Z., Li, J.-X., Lu, H., Liang, S., Cheng, K., & Xu, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3862210/v1
Classification and Clinical Features of Pulmonary Hypertension in Adults
Yasmin, F., Janjua, M. U., Najeeb, H., Pragya, A., Muhammad, H. S., Sharma, M., & Surani, S. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1004298
Marqueurs pronostiques et stratification du risque dans l’HTAP
Boucly, A. (2021) · theses.fr (ABES) · doi:10.70675/5ed4fe2cz1e57z41c5zac6az4af0eec45aa6
León, J. S. T., Pedraza, M. P. M., Pedraza, J. A. N., Medina, N. J. M., Patiño, M. A. D., López, J. A. E., Vega, S. Y. V., Rivero, J., & Campo, E. R. Z. (2024) · Ciencia Latina Revista Científica Multidisciplinar · doi:10.37811/cl_rcm.v8i2.10294
Clinical Progress of Chronic Obstructive Pulmonary Disease Complicated with Pulmonary Embolism
熊, 玉. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.1441088
Pulmonary Hypertension Associated with Chronic Lung Disease
Wang, Y., Estrada, R. A., Goel, K., Folz, R. J., & Sahay, S. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/011573398x266440240408080251
Pulmonary Arterial Hypertension Therapy in Pulmonary Hypertension Associated With Lung Diseases
Lin, J., & Hsu, C. (2024) · JACC Asia · doi:10.1016/j.jacasi.2024.03.001
Pulmonale Hypertonie assoziiert mit Lungenerkrankungen
Milger, K. (2024) · Pneumo News · doi:10.1007/s15033-024-3969-y
Pulmonary Hypertension: Current State of the Art (Part I)
Matusov, Y. P., Yaqoob, M., & Lewis, M. I. (2024) · Current Respiratory Medicine Reviews · doi:10.2174/1573398x2002240522161649
Koudstaal, T., Bogaard, H. J., & Boomars, K. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822951-4.00019-9
Sleep Disordered Breathing and Exercise in Pulmonary Hypertension
Singh, N., & Mullin, C. J. (2024) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-23.1.5
Interstitial lung disease: diagnosis and management principles
Ruggiero, C., & Fraser, E. (2024) · International Journal for Advancing Practice · doi:10.12968/ijap.2023.0057
Pediatric Pulmonary Hypertension
Haarman, M. G., & Berger, R. M. F. (2024) · Springer eBooks · doi:10.1007/978-3-031-07563-6_92
Zeng, Z., Pan, L., Li, Q., Wang, Q., Cheng, S., Chen, Q., Huang, J., Yang, R., Chen, H., & Zhan, Y. (2024) · Research Square · doi:10.21203/rs.3.rs-5175554/v1
Inbuilt Errors: A Call for Standardized Definitions
Pande, A., & Haouzi, P. A. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202411-2183le
Insights into Pulmonary Heart Disease at High Altitude: Hypoxia and PM2.5 Interactions
Xiao, Y., Ma, R., Liu, C., Wei, H. Y., Zhou, B., Gui, C., Yang, B., Cao, Y., Zhang, K., & Luo, B. (2025) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202409-1802rl
Hipertensi Pulmoner Terkait Penyakit Paru (Hipertensi Pulmoner Tipe 3)
Anggita, D., Amir, M., & Djaharuddin, I. (2025) · UMI Medical Journal · doi:10.33096/umj.v9i2.235
Gayen, S. K., Pescatore, J., Bittner, M., Naranjo, M., Criner, G. J., Weaver, S., D’Alonzo, G. E., Illipparambil, L. C., Rali, P. M., & Pourshahid, S. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-03538-8
Risk factors and outcomes of HPH in high-altitude residents via echocardiographic evaluation
Wang, S., Yu, L., Huang, L., Liu, X., Luo, F., Wang, W., & Wang, L. (2026) · BMC Cardiovascular Disorders · doi:10.1186/s12872-026-06081-4
Nomograms to predict severe PH and survival in COPD patients using non-invasive parameters
Sun, X., Cao, Y., Zhu, H., Xu, J., Pudasaini, B., Yang, W., Liu, J., & Guo, J. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1745477
Haemodynamics and post-exercise recovery response in COPD-PH and ILD-PH: An appraisal
Sengupta, S., Bhattacharyya, P., De, A., Karmakar, S., Chakraborty, W., & Saha, D. (2025) · Lung India · doi:10.4103/lungindia.lungindia_213_24
Jiang, Q., Wen, D., Peng, F., Wei, H., Fu, X., Xiong, Y., Ren, C., Li, X., Zhou, D., Wang, J., et al. (2025) · Journal of Visualized Experiments · doi:10.3791/67747
When Lipid Mediators Keep Lungs Whole: A Spontaneous, Female-Predominant Model of Emphysema
Girard, R., & Karmouty‐Quintana, H. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2025-0349ed
Diagnosis of Pulmonary Hypertension Associated With Lung Disease: A Call for Awareness
Castillo, D., Francesqui, J., Padilla, M., & Montani, D. (2025) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2025.07.001
Consenso ecuatoriano de hipertensión pulmonar
de la Vega, M. E. A., Cuadros-López, A., Arévalo, C. A., Herrera, J. A. A., Toro, M. D. C., Estupiñán, E. C., Mejía, A. F. C., Quincha, J. A. C., Rodriguez, C. C., Jaramillo, M. G. C., et al. (2025) · Metro Ciencia · doi:10.47464/metrociencia/vol33/2/2025/73-116
Pulmonary Hypertension Associated With Parenchymal Lung Disease
Ogunnaike, R., & Matusov, Y. P. (2025) · Advances in Pulmonary Hypertension · doi:10.21693/1933-088x-24.1.9
Sarcoidosis associated-pulmonary hypertension
Savale, L., Dorfmüller, P., & Humbert, M. J. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-822332-1.00012-7
CLINICAL AND PARACLINICAL PARTICULARITIES IN PATIENTS WITH COPD AND PULMONARY HYPERTENSION
Tudor, S. S., Stoleriu, G., Ferţu, D. I., Dumitru, C. N., Diaconu, C., Stanescu, C. M., & Manolache, N. (2025) · Romanian Journal of Oral Rehabilitation · doi:10.62610/rjor.2025.2.17.8
Poumon et sclérodermie systémique
HACHULLA, E. (2025) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2025.08.006
İdiyopatik Pulmoner Fibrozis Tanıdan Tedaviye Güncel Yaklaşım
Ölmez, H. (2025) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.3774
Diaz, A. L., Kumar, A., Kholoki, O., O’Sullivan, D. M., Swanson, K., Carollo, B., Bahgat, J., Farber, H. W., & Parikh, R. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14186395
Hackner, D., Lange, D., Gräfe, C., Andrassy, J., Koliogiannis, D., & Scheiermann, P. (2025) · Die Anaesthesiologie · doi:10.1007/s00101-025-01595-6
Pulmonale Hypertonie assoziiert mit Lungenerkrankungen
Yogeswaran, A., Skowasch, D., Foris, V., Wilkens, F. M., Zeder, K., Neurohr, C., Opitz, C. F., Ladage, D., Pfeuffer-Jovic, E., Wißmüller, M., et al. (2025) · Pneumologie · doi:10.1055/a-2625-4935
Kargin, T., & Bülbüloğlu, S. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70173
Burger, C. D., Wu, J., O'Brien, G. M., Makulova, N., Ward, T., Shamsunder, M. G., Shah, B., & Safdar, Z. (2025) · Pulmonary Circulation · doi:10.1002/pul2.70201
Bhattacharyya, P., Sengupta, S., Paul, M., Saha, D., De, A., Dey, D., & Ray, S. (2025) · International Journal of COPD · doi:10.2147/copd.s529320
Hasan, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-7810-5_61
Wu, Y., Qian, Y., Quan, R., Yang, Y., Zhang, G., Zhang, C., Yu, Z., Wu, W., Li, S., Wang, G., et al. (2025) · BMC Pulmonary Medicine · doi:10.1186/s12890-025-04025-w
Մինասյան, Ա. Մ., Meloyan, S. V., & Շ.Մ., Հ. (2025) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2025.40-37
Lee, I., Joh, J.-S., Lee, J. Y., Kim, J., Sin, S., Koo, H., & Jeong, I. (2025) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2025.0067
Metadata
- Authors
- Nathan, S. D., Barbera, J. A., Gaine, S. P., Harari, S., Martinez, F. J., Olschewski, H., Olsson, K. M., Peacock, A. J., Pepke-Zaba, J., Provencher, S., Weissmann, N., & Seeger, W.
- Affiliations
- Inova Fairfax Hospital (US)
- MultiMedica (IT)
- Medical University of Graz (AT)
- Medizinische Hochschule Hannover (DE)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Justus-Liebig-Universität Gießen (DE)
- ORCID
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2019-01
- Volume
- 53
- Issue
- 1
- Pages
- 1801914
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- PMC
- PMC6351338
- OpenAlex
- W2904463477
- Cited by
- 757
- References
- 94
- Citations by year
- 2026: 54 · 2025: 104 · 2024: 141 · 2023: 96 · 2022: 122 · 2021: 114 · 2020: 76 · 2019: 44
- FWCI
- 10.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- European Respiratory Journal (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by-nc)
- Funders
- American Thoracic Society
- Pfizer
- AstraZeneca
- Bayer
- GlaxoSmithKline
- Gilead Sciences
- Biogen
- Teva Pharmaceutical Industries
- United Therapeutics Corporation
- Sunovion
- Veracyte
- York University
- National Institutes of Health
- Genentech
- Actelion Pharmaceuticals
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Keywords
- pulmonary hypertension, chronic lung disease, hypoxia, hemodynamic assessment, quality of life, mortality risk, oxygen requirement
- MeSH terms
- Animals, Hypoxia, Antihypertensive Agents, Chronic Disease, Humans, Hypertension, Pulmonary, Lung Diseases, Interstitial, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.